Cargando…

IL-36 receptor agonist and antagonist imbalance drives neutrophilic inflammation in COPD

Current treatments fail to modify the underlying pathophysiology and disease progression of chronic obstructive pulmonary disease (COPD), necessitating alternative therapies. Here, we show that COPD subjects have increased IL-36γ and decreased IL-36 receptor antagonist (IL-36Ra) in bronchoalveolar a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baker, Jonathan R., Fenwick, Peter S., Koss, Carolin K., Owles, Harriet B., Elkin, Sarah L., Fine, Jay, Thomas, Matthew, El Kasmi, Karim C., Barnes, Peter J., Donnelly, Louise E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462491/ https://www.ncbi.nlm.nih.gov/pubmed/35763349 http://dx.doi.org/10.1172/jci.insight.155581

Ejemplares similares

IL36 is a critical upstream amplifier of neutrophilic lung inflammation in mice
por: Koss, Carolin K., et al.
Publicado: (2021)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
por: Belchamber, Kylie BR, et al.
Publicado: (2018)

Decreased phosphatase PTEN amplifies PI3K signaling and enhances proinflammatory cytokine release in COPD
por: Yanagisawa, Satoru, et al.
Publicado: (2017)

Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist
por: Macleod, Tom, et al.
Publicado: (2016)

Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice
por: Watanabe, Soichiro, et al.
Publicado: (2020)

Imbalance of dendritic cell co-stimulation in COPD
por: Stoll, Paul, et al.
Publicado: (2015)

Neutrophil adhesion molecules in experimental rhinovirus infection in COPD
por: Mallia, Patrick, et al.
Publicado: (2013)

Neutrophil extracellular traps are involved in enhanced contact hypersensitivity response in IL-36 receptor antagonist-deficient mice
por: Hasegawa, Yurie, et al.
Publicado: (2022)

Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist
por: Leaker, Brian R, et al.
Publicado: (2013)

Imbalance Between Injury and Defense in the COPD Emphysematous Phenotype
por: Bai, Shuang, et al.
Publicado: (2021)

Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD
por: Singh, R., et al.
Publicado: (2021)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

The Agonist-antagonist Myoneural Interface
por: Herr, Hugh, et al.
Publicado: (2021)

In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients
por: Milara, Javier, et al.
Publicado: (2019)

Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
por: Ganesan, Rajkumar, et al.
Publicado: (2017)

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?
por: Miravitlles, Marc, et al.
Publicado: (2018)

Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity
por: Cockayne, Debra A., et al.
Publicado: (2012)

Pathogenic triad in COPD: oxidative stress, protease–antiprotease imbalance, and inflammation
por: Fischer, Bernard M, et al.
Publicado: (2011)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Multitargeting nature of muscarinic orthosteric agonists and antagonists
por: Myslivecek, Jaromir
Publicado: (2022)

Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
por: Lattanzi, Roberta, et al.
Publicado: (2022)

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
por: Nock, Berthold A., et al.
Publicado: (2023)

N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist
Publicado: (1993)

Long-acting muscarinic antagonists vs. long-acting β (2) agonists in COPD exacerbations: a systematic review and meta-analysis
por: Maia, Israel Silva, et al.
Publicado: (2017)

A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β(2)-Agonist (LABA) Combinations in COPD
por: Sion, Katya Y. J., et al.
Publicado: (2017)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023)

Agonist Antagonist Interactions at the Rapidly Desensitizing P2X3 Receptor
por: Helms, Nick, et al.
Publicado: (2013)

Selectin Antagonists: Therapeutic Potential in Asthma and COPD
por: Romano, Suzanne J.
Publicado: (2012)

Glucocorticosteroids Differentially Regulate MMP-9 and Neutrophil Elastase in COPD
por: Vlahos, Ross, et al.
Publicado: (2012)

CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin
por: Keir, Holly R., et al.
Publicado: (2020)

Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance
por: El-Helou, Nancy, et al.
Publicado: (2013)

Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists
por: Ghosh, Puja, et al.
Publicado: (2023)

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
por: Fenwick, Peter S., et al.
Publicado: (2015)

Combination of a Rapidly Penetrating Agonist and a Slowly Penetrating Antagonist Affords Agonist Action of Limited Duration at the Cellular Level
por: Pearce, Larry V., et al.
Publicado: (2019)

Effects of Adrenergic Agonists and Antagonists on Cardiopulmonary Function During Normobaric Hypoxia in Rat
por: Bölter, Christian, et al.
Publicado: (2019)

7q36 deletion and 9p22 duplication: effects of a double imbalance
por: Pelegrino, Karla de Oliveira, et al.
Publicado: (2013)

Editorial: The importance of Th17/Treg imbalance in asthma and COPD development and progression
por: Lopes, Fernanda Degobbi T. Q. S., et al.
Publicado: (2022)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
por: D’Urzo, Anthony D, et al.
Publicado: (2018)

Agonistic and antagonistic estrogens in licorice root (Glycyrrhiza glabra)
por: Simons, Rudy, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_itmbklqhrp8hhfejrbdj51jtjq